New Competition Rules for R&D Cooperation Agreements
by Stephan Manuel Nagel, LL.M. (EUI) and Dr. Nora E. Wessendorf, LL.M. (Washington)
Does a clinical trial render the pharmaceutical formulation used therein public?
OLG Celle on the obligations of distributors under Art. 14 MDR when distributing non-compliant medical devices in the context of unfair competition law
by Dr. Daniel Tietjen and Sherin Sayed
Taylor Wessing advises Emerald Technology Ventures on investment in Colibri Energy
With this investment, Emerald Technology Ventures supports the development and growth of Colibri Energy, a provider of lithium-ion battery systems for vehicles in airport and industrial logistics.
by multiple authors
Is it 'unfair' for a university to own student-created IP? Reflections on OUI v ONI
by Adrian Toutoungi and Lauren Mounteney
Disproportionality in Pharma-Cases: A Follow-up
by Verena Bertram and Dr. Nora E. Wessendorf, LL.M. (Washington)
Dos & Don’ts in Research Collaborations
Are your contracts UPC ready? How to triage your key IP agreements and templates
by multiple authors
The impact of the National Security and Investment Act 2021
by Philip Shepherd and Paolo Palmigiano